Text Size

Ranibizumab for the Inhibition of Neovascularization in Pterygia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sonia Yoo, Bascom Palmer Eye Institute
ClinicalTrials.gov Identifier:
NCT00768963
First received: October 7, 2008
Last updated: July 24, 2012
Last verified: July 2012
History of Changes
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
No publications provided by Bascom Palmer Eye Institute

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):